Fonte: Anais. Nome do evento: Reunião Nacional de Pesquisa da Malária. Unidades: ICB, FCF, BIOTECNOLOGIA
Assuntos: ANGIOTENSINAS, INIBIDORES DE ENZIMAS
ABNT
SANTOS, Yasmin Silva et al. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. 2022, Anais.. Rio de Janeiro: Fiocruz, 2022. . Acesso em: 01 set. 2024.APA
Santos, Y. S., Azevedo, M. S. P. de, Gamon, T. H. M., Marinho, C. R. F., Luvizotto, M. C. R., Durigon, E. L., et al. (2022). Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. In Anais. Rio de Janeiro: Fiocruz.NLM
Santos YS, Azevedo MSP de, Gamon THM, Marinho CRF, Luvizotto MCR, Durigon EL, Carvalho LJ de M, Epiphanio S. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. Anais. 2022 ;[citado 2024 set. 01 ]Vancouver
Santos YS, Azevedo MSP de, Gamon THM, Marinho CRF, Luvizotto MCR, Durigon EL, Carvalho LJ de M, Epiphanio S. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. Anais. 2022 ;[citado 2024 set. 01 ]